Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00950885 · ClinicalTrials.gov registry record · NA
Melatonin Treatment for Induced Transient Insomnia
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00950885 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 42 participants.
The verdict
NCT00950885, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Melatonin supplements have been reported to be an effective treatment for circadian rhythm sleep disorders, including shift work dyssomnia, jet-lag, delayed sleep phase syndrome, and sleep disruption suffered by many blind individuals. However, the mechanism(s) by which melatonin affects the timing of sleep are not well-understood. The purpose of this study is to determine if melatonin improves sleep and performance on a schedule simulating eastward travel. This study will provide information regarding the mechanism of action of melatonin that will be critical for the use of melatonin as a treatment for circadian rhythm sleep disorders.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Low Dose Melatonin
- BIOLOGICAL High Dose Melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00950885
The ClinicalTrials.gov registry entry for NCT00950885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00950885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00950885 about?
NCT00950885 is a clinical study titled "Melatonin Treatment for Induced Transient Insomnia". Melatonin supplements have been reported to be an effective treatment for circadian rhythm sleep disorders, including shift work dyssomnia, jet-lag, delayed sleep phase syndrome, and sleep disruption suffered by many blind individuals. However, the mechanism(s) by which melatonin affects the timing ...
What is the current status of trial NCT00950885?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2009-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00950885?
The interventions under investigation include: Placebo (BIOLOGICAL), Low Dose Melatonin (BIOLOGICAL), High Dose Melatonin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00950885?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.